Skip to content

Sprint Fidelis Lead in the Sunday Mail 11 Dec 2011

9 December 2011

At all times patient safety is Medtronic’s top priority. As such we are committed to ensuring our products are of the highest quality and are processed through rigorous safety and technical assessment prior to distribution. However, no medical device or procedure, regardless of design, can be risk-free.

Medtronic is a clear industry leader in investing in long term monitoring studies and reporting those results for our products and responding quickly to provide information and recommendations to treating physicians and regulators where any issues are identified.

Medtronic Australasia is aware of and abides by, our obligations under TGA regulations. In the cases of Sprint Fidelis, Sigma and Kappa pacemakers, all actions have been undertaken in accordance with the TGA Uniform Recall Protocol for Therapeutic Goods (URPTG) guidelines and the TGA Adverse Events reporting requirements as per the Australian Regulatory Guidelines for Medical Devices (ARGMD).

Patients should be assured that wherever issues are identified with products, doctors are provided with extensive information and recommendations in order to manage their patients appropriately. If patients have concerns with regards to their condition their doctor is the appropriate person to discuss these concerns.

No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: